Novo Nordisk showed ‘extraordinary growth’ but faces competitive weight loss market (CNBC)

John Rountree, Managing Partner at Novasecta, comments on Danish pharma giant Novo Nordisk’s first-quarter earnings.

Watch John’s interview here.